These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38026973)

  • 1. Cathepsin V regulates cell cycle progression and histone stability in the nucleus of breast cancer cells.
    Sereesongsaeng N; Burrows JF; Scott CJ; Brix K; Burden RE
    Front Pharmacol; 2023; 14():1271435. PubMed ID: 38026973
    [No Abstract]   [Full Text] [Related]  

  • 2. Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer.
    Sereesongsaeng N; McDowell SH; Burrows JF; Scott CJ; Burden RE
    Breast Cancer Res; 2020 Dec; 22(1):139. PubMed ID: 33298139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ.
    Toss M; Miligy I; Gorringe K; Mittal K; Aneja R; Ellis I; Green A; Rakha E
    J Clin Pathol; 2020 Feb; 73(2):76-82. PubMed ID: 31444238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin V drives lung cancer progression by shaping the immunosuppressive environment and adhesion molecules cleavage.
    Zhu L; Zeng Q; Wang J; Deng F; Jin S
    Aging (Albany NY); 2023 Dec; 15(23):13961-13979. PubMed ID: 38078882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTSV (cathepsin V) promotes bladder cancer progression by increasing NF-κB activity.
    Xia Y; Ge M; Xia L; Shan G; Qian H
    Bioengineered; 2022 Apr; 13(4):10180-10190. PubMed ID: 35443863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated Cathepsin V Serves as a Prognostic Marker in Lung Cancer.
    Yang L; Zeng Q; Deng Y; Qiu Y; Yao W; Liao Y
    Front Oncol; 2022; 12():876245. PubMed ID: 35494076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice.
    Sevenich L; Hagemann S; Stoeckle C; Tolosa E; Peters C; Reinheckel T
    Biochimie; 2010 Nov; 92(11):1674-80. PubMed ID: 20347002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy.
    Huang K; Gao L; Yang M; Wang J; Wang Z; Wang L; Wang G; Li H
    Int J Biochem Cell Biol; 2017 Aug; 89():6-15. PubMed ID: 28522343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.
    Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Hyun YL; Choi J
    Breast Cancer Res Treat; 2011 Nov; 130(2):365-75. PubMed ID: 21184271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Praeruptorin B Mitigates the Metastatic Ability of Human Renal Carcinoma Cells through Targeting CTSC and CTSV Expression.
    Lin CL; Hung TW; Ying TH; Lin CJ; Hsieh YH; Chen CM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Role of Cathepsin L/V in Regulating Endothelial Cell Senescence.
    Li C; Liu Z; Chen M; Zhang L; Shi R; Zhong H
    Biology (Basel); 2022 Dec; 12(1):. PubMed ID: 36671735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
    Jiang Q; Zhang H; Zhang P
    J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
    Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
    Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells.
    Bach AS; Derocq D; Laurent-Matha V; Montcourrier P; Sebti S; Orsetti B; Theillet C; Gongora C; Pattingre S; Ibing E; Roger P; Linares LK; Reinheckel T; Meurice G; Kaiser FJ; Gespach C; Liaudet-Coopman E
    Oncotarget; 2015 Sep; 6(29):28084-103. PubMed ID: 26183398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanosome degradation in epidermal keratinocytes related to lysosomal protease cathepsin V.
    Homma T; Kageyama S; Nishikawa A; Nagata K
    Biochem Biophys Res Commun; 2018 Jun; 500(2):339-343. PubMed ID: 29654760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.
    Pateetin P; Pisitkun T; McGowan E; Boonyaratanakornkit V
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105560. PubMed ID: 31809870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
    Cheng T; Hitomi K; van Vlijmen-Willems IM; de Jongh GJ; Yamamoto K; Nishi K; Watts C; Reinheckel T; Schalkwijk J; Zeeuwen PL
    J Biol Chem; 2006 Jun; 281(23):15893-9. PubMed ID: 16565075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of IMPORTIN-4 bound to the H3-H4-ASF1 histone-histone chaperone complex.
    Bernardes NE; Fung HYJ; Li Y; Chen Z; Chook YM
    Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2207177119. PubMed ID: 36103578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
    Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
    Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.